FDA — authorised 29 January 1964
- Application: ANDA060869
- Marketing authorisation holder: PROTER
- Local brand name: OXYTETRACYCLINE HYDROCHLORIDE
- Indication: CAPSULE — ORAL
- Status: approved
FDA authorised OXYTETRACYCLINE HYDROCHLORIDE on 29 January 1964
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 29 January 1964; FDA authorised it on 8 September 1964; FDA authorised it on 9 August 1967.
PROTER holds the US marketing authorisation.